The candidate oncogene ZNF217 is frequently amplified in colon cancer

Journal of Pathology

Volumn 204, Issue 3, 2004, Pages 282-288

  Rooney, Patrick H ^a   Boonsong, Attasit ^a   McFadyen, Morag C E ^a   McLeod, Howard L ^a,b   Cassidy, James ^a,c   Curran, Stephanie ^a   Murray, Graeme I ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Colon cancer; Comparative genomic hybridization; Gene copy number; Real time PCR; ZNF217

Indexed keywords

BETA GLOBIN; DNA; ONCOPROTEIN; PROTEIN ZNF217; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 20Q; CHROMOSOME MAP; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; COLON CARCINOMA; COLON TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DEVICE; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENETIC GAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADENOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 7244257505     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1632     Document Type: Article

References (24)

1. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi O-P. Genome screening by comparative genomic hybridisation. Trends Genet 1997; 13: 405-409.
2. Rooney PH, Murray GI, Stevenson DAJ, Haites NE, Cassidy J, McLeod HL. Comparative genomic hybridization and chromosomal instability in solid tumours. Br J Cancer 1999; 80: 862-873.
3. Weiss MM, Snijders AM, Kuipers EJ, et al. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 2003; 200: 320-326.
4. Rooney PH, Boonsong A, McKay JA, et al. Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer 2001; 85: 1492-1498.
5. Collins C, Rommens JM, Kowbel D, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 1998; 95: 8703-8708.
6. Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res 2001; 61: 1250-1254.
7. Tanner MM, Granman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000; 6: 1833-1839.
8. Curran S, McKay JA, McLeod HL, Murray GI. Laser capture microscopy. J Clin Pathol: Mol Pathol 2000; 53: 64-68.
9. Curran S, Murray GI. Tissue microdissection and its applications in pathology. Curr Diagn Pathol 2002; 8: 183-192.
10. Lehmann U, Glöckner S, Kleeberger W, Feist H, von Wasielewski R, Kreipe H. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. J Pathol 2000; 156: 1855-1864.
11. Boonsong A, Marsh S, Rooney PH, Stevenson DAJ, Cassidy J, McLeod HL. Characterisation of the topisomerase I locus in human colorectal cancer. Cancer Genet Cytogen 2000; 121: 56-60.
12. Lawrie LC, Curran S, McLeod HL, Fothergill JE, Murray GI. Applications of laser capture microdissection and proteomics in colon cancer. J Clin Pathol: Mol Pathol 2001; 54: 253-258.
13. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991; 88: 7276-7280.
14. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR: real time monitoring of DNA amplification reactions. Biotechniques 1993; 11: 1026-1030.
15. McFadyen MCE, Rooney PH, Melvin WT, Murray GI. Quantitative analysis of the Ah receptor CYP1B1/CYP1A1 signaling pathway. Biochem Pharmacol 2003; 65: 1663-1674.
16. Glöckner S, Lehmann U, Wilke N, Kleeberger W, Länger F, Kreipe H. Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR. Pathobiology 2000; 68: 173-179.
17. Hidaka S, Yasutake, T, Takeshita H, et al. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000; 6: 2712-2717.
18. Ginzinger DG, Godfrey TE, Nigro J, et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000; 60: 5405-5409.
19. Freier K, Joos S, Flechtenmacher C, et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003; 63: 1179-1182.
20. Reid T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996; 15: 234-245.
21. Nakao K, Shirbusawa M, Tsunoda A, et al. Genetic changes in primary colorectal cancer by comparative genomic hybridization. Surg Today 1998; 28: 567-569.
22. Reid T, Liyanage M, du Manoir S, et al. Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J Mol Med 1997; 75: 801-814.
23. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001; 188: 143-160.
24. De Angelis PM, Clausen OPF, Schjolberg A, Stokke T. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999; 80: 526-535.